The Journal of Organic Chemistry
Article
Ethyl 4-Hydroxy-2-(4-methoxyphenyl)-4-trifluoromethyl-4,5-dihy-
drooxazole-5-carboxylate 3c and Ethyl 2-(4-Methoxybenzamido)-
4,4,4-trifluoro-3,3-dihydroxybutanoate 2c. According to General
Method A, ethyl 2-diazo-4,4,4-trifluoro-3-oxobutanoate 1 (200 mg,
0.95 mmol), 4-methoxybenzamide (190 mg, 1.26 mmol), and
rhodium(II) acetate (8.4 mg, 2 mol %) gave (i) ethyl 4-hydroxy-2-(4-
methoxyphenyl)-4-trifluoromethyl-4,5-dihydrooxazole-5-carboxylate 3c
as a colorless solid (120 mg, 38%): mp 125−127 °C; (Found: M +
Na+, 356.0700. C14H14F3NO5 + Na+ requires 356.0716); νmax (CHCl3)/
cm−1 3689, 3568, 3011, 1758, 1639, 1610, 1513, 1464, 1425, 1377, 1356,
1307, 1259, 1192, 1173, 1096; δH (400 MHz; CDCl3) 8.02 (2 H, d, J
8.8 Hz), 6.97 (2 H, d, J 8.8 Hz), 5.20 (1 H, s), 4.36 (2 H, m), 4.19 (1 H,
br), 3.90 (3 H, s), 1.36 (3 H, t, J 7.0 Hz); δC (126 MHz; CDCl3) 169.6
(C), 165.3 (C), 163.7 (C), 131.5 (CH), 122.6 (q, J 284.8 Hz, CF3),
117.1 (C), 114,0 (CH), 98.5 (q, J 32.7 Hz, C), 79.9 (CH), 62.2 (CH2),
55.5 (Me), 14.0 (Me); δF (377 MHz; CDCl3) −81.6 (s, CF3). (ii) Ethyl
4,4,4-trifluoro-3,3-dihydroxy2-(4-methoxybenzamido)butanoate 2c was
also given as a colorless crystalline solid (133 mg, 40%): mp 71−74 °C;
(Found: M + Na+, 374.0815. C14H16F3NO6 + Na+ requires 374.0822);
νmax (CHCl3)/cm−1 3690, 3571, 3007, 1738, 1668, 1606, 1577, 1496,
1442, 1375, 1343, 1311, 1259, 1182, 1096, 1030; δH (400 MHz;
(CD3)2SO) 8.10 (1 H, d, J 9.0 Hz), 7.83 (2 H, d, J 8.7 Hz), 7.59
(1 H, s), 7.52 (1 H, s), 7.05 (2 H, d, J 8.7 Hz), 4.93 (1 H, d, J 9.0 Hz),
4.13 (2 H, q, J 7.1 Hz), 3.83 (3 H, s), 1.20 (3 H, t, J 7.1 Hz); δC (100
MHz; CDCl3) 168.6 (C), 166.0 (C), 162.5 (C), 129.7 (CH), 125.8
(CH), 122.0 (q, J 287.8 Hz, CF3), 114.2 (C), 93.0 (q, J 32.2 Hz, C),
61.4 (CH2), 56.3 (Me), 55.9 (CH), 13.8 (Me); δF (377 MHz; CDCl3)
−81.6 (s, CF3).
(152 mg, 0.60 mmol), and anhydrous dichloromethane (15 mL).
Once the solids had dissolved completely, triethylamine (173 μL,
1.24 mmol) and a solution of ethyl 2-(2-bromobenzamido)-4,4,4-tri-
fluoro-3,3-dihydroxybutanoate 2b (119.7 mg, 0.30 mmol) in dichloro-
methane (5 mL) were added. The mixture was allowed to stir under
argon overnight at room temperature and then concentrated in vacuo.
The product was purified by chromatography over silica using 20%
ethyl acetate in light petroleum to give the title compound 4b as
colorless solid (25.7 mg, 75%): mp 52−55 °C; (Found: M + H+,
363.9807. C13H979BrF3NO3 + H+ requires 363.9791); νmax (CHCl3)/
cm−1 3684, 3409, 2986, 2854, 1740, 1605, 1571, 1459, 1398, 1379,
1361, 1317, 1246, 1153, 1028; δH (400 MHz, CDCl3) 8.04 (1 H, d, J
8.0 Hz), 7.78 (1 H, d, J 8.0 Hz), 7.49 (1 H, t, J 8.0 Hz), 7.42 (1 H, t, J
8.0 Hz), 4.50 (2 H, q, J 7.2 Hz), 1.46 (3 H, t, J 7.2 Hz); δC (100 MHz;
CDCl3) 160.5 (C), 159.2 (C), 142.5 (q, J 44.0 Hz, C), 134.6 (CH),
133.2 (C), 133.1 (CH), 133.2 (CH), 127.5 (C), 126.3 (C), 121.7
(CH), 118.3 (q, J 269.0 Hz, CF3), 62.3 (CH2), 13.9 (Me); δF (377
MHz; CDCl3) −61.01 (s, CF3).
General Method B. Phosphoryl chloride (20 μL, 0.21 mmol) was
added to a solution of the ethyl 4-hydroxy-2-aryl-4-trifluoromethyl-4,5-
dihydrooxazole-5-carboxylate 3 (0.09 mmol) in DMF (300 μL) at
0 °C. The mixture was stirred at room temperature for 16 h, poured
into ice-water (1 mL), and then extracted with EtOAc (3 × 2 mL).
The organic layers were dried over MgSO4 and concentrated under
reduced pressure. The residue was purified over silica using 10% ethyl
acetate in light petroleum to give the ethyl 2-aryl-4-trifluoromethylox-
azole-5-carboxylate 5.
Ethyl 2-Phenyl-4-trifluoromethyloxazole-5-carboxylate 5a. Ac-
cording to General Method B, ethyl 4-hydroxy-2-phenyl-4-trifluor-
omethyl-4,5-dihydrooxazole-5-carboxylate 3a (28.5 mg, 0.09 mmol)
gave ethyl 2-phenyl-4-trifluoromethyloxazole-5-carboxylate 5a as a
colorless solid (19.5 mg, 73%): mp 44−47 °C (lit.,38 no data);
(Found: M + H+, 286.0687. C13H10F3NO3 + H+ requires 286.0686);
νmax (CHCl3)/cm−1 2987, 2929, 1739, 1609, 1560, 1488, 1451, 1398,
1379, 1362, 1329, 1315, 1276, 1151, 1037; δH (400 MHz, CDCl3) 8.17
(2 H, d, J 8.0 Hz), 7.50−7.60 (3 H, m), 4.48 (2 H, q, J 7.2 Hz), 1.44 (3
H, t, J 7.2 Hz); δC (100 MHz; CDCl3) 162.7 (C), 156.1 (C), 139.9
(C), 136.7 (q, J 44.0 Hz, C), 132.4 (CH), 129.2 (CH), 127.7 (CH),
125.2 (C), 119.8 (q, J 268.0 Hz, CF3), 62.7 (CH2), 14.0 (Me); δF (377
MHz; CDCl3) −61.84 (s, CF3).
Ethyl 2-(4-bromophenyl)-4-hydroxy-4-trifluoromethyl-4,5-dihy-
drooxazole-5-carboxylate 3d and Ethyl 2-(4-Bromobenzamido)-
4,4,4-trifluoro-3,3-dihydroxybutanoate 2d. According to General
Method A, ethyl 2-diazo-4,4,4-trifluoro-3-oxobutanoate 1 (200 mg,
0.95 mmol), 4-bromobenzamide (252 mg, 1.26 mmol), and
rhodium(II) acetate (8.4 mg, 2 mol %) gave (i) ethyl 4-hydroxy-2-
(4-bromophenyl)-4-trifluoromethyl-4,5-dihydrooxazole-5-carboxylate
3d as a colorless solid (119 mg, 33%): mp 103−105 °C; (Found: M +
Na+, 403.9716. C13H1179BrF3NO4 + Na+ requires 403.9721); νmax
(CHCl3)/cm−1 3690, 3011, 1759, 1646, 1584, 1569, 1489, 1403, 1377,
1354, 1300, 1256, 1182, 1160; δH (400 MHz; (CD3)2SO) 8.18
(1 H, s), 7.90 (2 H, d, J 8.7 Hz), 7.80 (2 H, d, J 8.7 Hz), 5.50 (1 H, s),
4.22 (2 H, q, J 7.1 Hz), 1.22 (3 H, t, J 7.1 Hz); δC (126 MHz; CDCl3)
169.1 (C), 164.9 (C), 132.1 (CH), 131.0 (CH), 128.8 (C), 123.6 (C),
122.6 (q, J 284.8 Hz, CF3), 98.5 (q, J 33.0 Hz, C), 80.2 (CH), 62.4
(CH2), 14.0 (Me); δF (377 MHz; CDCl3) −81.9 (s, CF3). (ii) Ethyl 2-
(4-bromobenzamido)-4,4,4-trifluoro-3,3-dihydroxybutanoate 2d was
also given as a colorless crystalline solid (162 mg, 43%): mp 111−
114 °C; (Found: M + Na+, 421.9822. C13H1379BrF3NO5 + Na+ requires
421.9827); νmax (CHCl3)/cm−1 3690, 3568, 3011, 1740, 1716, 1645,
1593, 1568, 1516, 1480, 1398, 1341, 1314, 1258, 1145, 1070; δH (400
MHz; (CD3)2SO) 8.37 (1 H, d, J 9.0 Hz), 7.80 (2 H, d, J 8.7 Hz), 7.72 (2
H, d, J 8.7 Hz), 7.59 (1 H, s), 7.52 (1 H, s), 4.93 (1 H, d, J 9.0 Hz), 4.13
(2 H, q, J 7.1 Hz), 1.20 (3 H, t, J 7.1 Hz); δC (126 MHz; CDCl3) 169.1
(C), 167.6 (C), 132.1 (CH), 131.3 (C), 128.9 (CH), 127.5 (C), 122.0 (q,
J 287.8 Hz, CF3), 93.8 (q, J 32.2 Hz, C), 63.5 (CH2), 55.3 (CH), 13.8
(Me); δF (377 MHz; CDCl3) −81.6 (s, CF3).
Ethyl 2-(2-Bromophenyl)-4-trifluoromethyloxazole-5-carboxylate
5b. According to General Method B, ethyl 2-(2-bromophenyl)-4-
hydroxy-4-trifluoromethyl-4,5-dihydrooxazole-5-carboxylate 3b (36.1
mg, 0.09 mnmol) gave ethyl 2-(2-bromophenyl)-4-trifluoromethylox-
azole-5-carboxylate 5b as colorless solid (23.7 mg, 69%): mp 62−63
°C; (Found: M + H+, 363.9807. C13H979BrF3NO3 + H+ requires
363.9791); νmax (CHCl3)/cm−1 3689, 3606, 3053, 2988, 1737, 1602,
1549, 1523, 1472, 1455, 1398, 1382, 1322, 1296, 1255, 1175, 1157,
1012; δH (400 MHz, CDCl3) 8.06 (1 H, d, J 8.0 Hz), 7.78 (1 H, d, J
8.0 Hz), 7.39−7.52 (2 H, m), 4.50 (2 H, q, J 7.2 Hz), 1.46 (3 H, t, J
7.2 Hz); δC (126 MHz; CDCl3) 161.2 (C), 155.9 (C), 140.4 (C),
135.9 (q, J 41.0 Hz, C), 134.8 (CH), 133.2 (CH), 132.1 (CH), 127.6
(C), 126.4 (CH), 120.7 (C), 119.7 (q, J 268.0 Hz, CF3), 62.5 (CH2),
14.0 (Me); δF (377 MHz; CDCl3) −61.71 (s, CF3).
Conversion of 2 and 3 into Oxazoles 4 and 5. Ethyl 2-(2-
Bromophenyl)-5-trifluoromethyloxazole-4-carboxylate 4b. To a dry
flask were added triphenylphosphine (157 mg, 0.60 mmol), iodine
1400
dx.doi.org/10.1021/jo202201w | J. Org. Chem. 2012, 77, 1396−1405